dose - uroweb.ru · smart and iot healthcare 2017 cagr 30.2% development of technologies and...
Post on 30-May-2020
2 Views
Preview:
TRANSCRIPT
dose.io Smart medication dispenser with cloud-based platform for collecting and analyzing data on adherence to therapy.
getdose.io // hello@getdose.io
2. Death of 200k patients annually
1. Non-adherence to therapy
3. Pharmaceutical companies lose revenue, $137.5B annually
Problem Approximately 50% of people do not take drugs as prescribed. According to World Health Organization.
1/20
5. Insurance companies isn’t protected f rom people who don’t adhere to the prescribed rules for taking medications
4. The state suffers additional healthcare costs due to low adherence
Adherence Drop-Off
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22MONTHS
AD
HER
ENC
E
0%
10%20%
30%40%
50%60%70%80%90%
100% СLUSTER 1
СLUSTER 2
СLUSTER 3
ONCOLOGY - BREASTDIABETSCARDIOVASCULAR - HYPRETENSIONCARDIOVASCULAR - STATIN
GASTROINTESTINAL - PPIONCOLOGY - PROSTATENEUROSCIENCE - ANTI PSYCHOTIC
RESPIRATORY - ASTHMA INHALED CSRESPIRATORY - ASTHMA BRONCHODILATOR
2/20
Problem
Kidney
Oncological
Blood
Organ transplant patients
Endocrine
The occurrence of relapses
Hospitalization
The increase in treatment costs
A significant role in the treatment of patients is played by their adherence to prescribed therapy. Regardless of the medication, it’s important to follow the systematic reception, follow the doctor’s recommendations, otherwise it can very often lead to disastrous consequences. For example: one missed dose can increase drug resistance, which will complicate further treatment.
What is the result of non-adherence to therapy? Disease area:
Switching to other medications or adding new ones
3/20
What is Resistance?
INCREASED RISK OF SIDE EFFECTS
INCREASED RISK OF RESISTANCE
DR
UG
LEV
ELS
DOSEDOSE DOSE DOSE
Minimum level
Taking meds on time
INCREASED RISK OF SIDE EFFECTS
INCREASED RISK OF RESISTANCE
Missed doseDOSE
Missing a dose or taking it late
TIME4/20
Сonfirmation of problem
Capgemini Consulting — Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence https://www.capgemini.com/wp-content/uploads/2017/07/Estimated_Annual_Pharmaceutical_Revenue _Loss_Due_to_Medication_Non-Adherence.pdf
S3 Connected Health — How The Pharma Industry Is Tackling Medication Adherence https://www.s3group.com/wp-content/uploads/sites/4/2015/06/Medication-Adherence-Pharma-Survey.pdf
Bayer — Medication Adherence http://pharma.bayer.com/en/commitment-responsibility/benefits-and-risks-of-drugs/medication-adherence/
Articles and studies:
1
2
3
5/20
SolutionThe device that replaces the usual cap and keeps track of medication, reminds to reception, sends notifications to smartphone.
Doctors
Profits for:Patients Pharma
Reduced drug costs
Improving the quality of therapy
A flexible tool for interacting with a doctor
Ability to prolong medication
Permanent Observation ProgramDepersonalized global statisticsA strong tool for making both marketing and strategic
Convenient and effective way to interact with the patient
6/20
Government
Insurance companies
Reducing healthcare costsA tool to counteract socially significant diseases
Risk Hedging
Technology
Cloud
Patient
Doctor
Key feature: device transmits data directly to the server, bypassing any devices, which allows to configure and monitor patient prof iles in realtime. This greatly simplifies the user experience of dose.io, it's very important for senior citizens.
8/20
MarketSmart and IoT healthcare
2017
CAGR 30.2%Development of technologies and improvement of technological processes allows to reduce the final cost of production
$ 56.1 B
$ 267.6 B
According to a P&S Intelligence
Growing number of patients
2023
New laws on telemedicine 9/20
Competitors
All existing solutions for transmitting the data need to be connected to intermediate devices and doesn’t account for dose and residue
RoundReffill
$39.99+
11/20
Competitive Advantages
Lower CostCompactness and autonomy
Independence Dose and residue accounting
Design and better UX
Various modifications
$
12/20
Business ModelProblem Solution
Key Metrics
Cost Structure Revenue Streams
Channels
Unique Value Proposition
Unfair Advantages
Customer Segments
Early Adopters
Experience with overdose and death Pharmaceutical companies lose revenue Low treatment efficiency
Marketing Certification Device manufacturing Infrastructure Salary fund
Smart pill dispenser for medication and cloud platform for data analysis and
Increase adherence Cost reduction for patients CAC/LTV (b2b)
DaaS and analytics Device sale SaaS
Biohackers
New laws on telemedicine
Online sales Pharmacies Clinics
Low cost No need for other connections Track residue of medications Compactness and autonomy
Chronic patients People who like BAA People in critical conditions
13/20
Market Adoption
Partnerships wiсh pharma
SaaS platform development
DaaS platform development
Scaling technology to other solutions
14/20
UPTO
DATE
Traction
We have a commit to collaboration with SH - Pharma
Prototype developed
We started!
Jule
August
January 15/20
We’re negotiating with pharma companies
about pilot launch
Team
Egor Gargolin CEO Managed projects with Micron. Studying for a BSc MIET.
Kirill Frolov СPO 3 years of experience in product management and development. Studying for a BSc BMSTU.
Vladimir Bogdanov CTO 3 years in the development of IoT devices. Hardware engineer in NVP Bolid. BSc MIET.
Anton Pchelkin Fullstack Developer 8 years in development. Team Lead at Moqod. CTO Fabinka. ex Software Engineer at Algont.
16/20
Mentors
Pavel Bilenko BD Advisor Head of Industry 4.0 Educational Programmes at Moscow School of Management SKOLKOVO. CEO Tekner.
Igor Shaderkin Medical Advisor Head of Electronic Health Laboratory, Institute of Digital Medicine FMSMU (Sechenov University).
17/20
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi
hi hi
hi
hi
hi
hi
hi
hi
Contacts
Egor Gargolin +7 905 727 06 98 facebook.com/bariors bariors98@gmail.com
Kirill Frolov+7 926 160 98 63 facebook.com/m2750g kirill.nik25@gmail.com
egor-gargolin kirill-frolov
20/20
top related